Nel corso del 2021, Giampaolo Perna è stato coautore di 10 nuove pubblicazioni scientifiche:

 

1.Perna G, Caldirola D. COVID-19 and Panic Disorder: Clinical considerations for the most physical among mental disorders" Brazilian Journal of Psychiatry, 2021, 43: 110-111.

2.Perna G, Daccò S, Alciati A, Cuniberti F, De Berardis D, Caldirola D. Childhood maltreatment history for guiding personalized antidepressant choice in major depressive disorder: preliminary results from a systematic review. Progress in Neuropsychopharmacology & Biological Psychiatry, 2021, 107: 110208.

3. Marlene Rosen, Linda T. Betz, Frauke Schultze-Lutter, Katharine Chisholm, Theresa K. Haidl, Lana Kambeitz-Ilankovic, Alessandro Bertolino, Stefan Borgwardt, Paolo Brambilla, Rebekka Lencer, Eva Meisenzahl, Stephan Ruhrmann, Raimo K.R. Salokangas, Rachel Upthegrove, Stephen J. Wood, Nikolaos Koutsouleris, Joseph Kambeitz & the PRONIA Consortium. Towards Clinical Application of Prediction Models for Transition to Psychosis: A Systematic Review and External Validation Study in the PRONIA Sample, Neuroscience & Biobehavioral Reviews, 2021 Jun;125:478-492

4. Penzel N, Antonucci LA, Betz LT, Sanfelici R, Weiske J, Pogarell O, Cumming P, Quednow BB, Howes O, Falkai P, Upthegrove R, Bertolino A, Borgwardt S, Brambilla P, Lencer R, Meisenzahl E, Rosen M, Haidl T, Kambeitz-Ilankovic L, Ruhrmann S, Salokangas RRK, Pantelis C, Wood SJ, Koutsouleris N, Kambeitz J; PRONIA Consortium. Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis. Neuropsychopharmacology, 2021, 46:1484-1493.

5. Wenzel J, Haas SS, Dwyer DB, Ruef A, Oeztuerk OF, Antonucci LA, von Saldern S, Bonivento C, Garzitto M, Ferro A, Paolini M, Blautzik J, Borgwardt S, Brambilla P, Meisenzahl E, Salokangas RKR, Upthegrove R, Wood SJ, Kambeitz J, Koutsouleris N, Kambeitz-Ilankovic L; PRONIA consortium. Cognitive subtypes in recent onset psychosis: distinct neurobiological fingerprints? Neuropsychopharmacology, 2021, 46: 1475-1483.

6. De Berardis D, Vellante F, Pettorruso M, Lucidi L, Tambelli A, Di Muzio I, Gianfelice G, Ventriglio A, Fornaro M, Serafini G, Pompili M, Perna G, Fraticelli S, Martinotti G, di Giannantonio M. Suicide and genetic biomarkers: toward personalized tailored-treatment with lithium and clozapine. Curr Pharm Des. 2021, 27:3293-3304. 

7. Antonio V, Antonello B, Donato F, Iris B, Giovanna V, Dario DS, Edwige C, Ilaria DG, Pettorruso M, Perna G, Valchera A, Domenico B. Oxidative Stress in the Early Stage of Psychosis. Curr Top Med Chem. 2021 21:1457-1470. 

8. Perna G, Nemeroff CB. Can Personalized Medicine Mitigate Confirmation Bias in Mental Health? Brazilian Journal of Psychiatry, 2021 S1516.

9. Caldirola D, Daccò S, Cuniberti F, Grassi M, Lorusso S, Diaferia G, Perna G.   Elevated C-reactive protein levels across diagnoses: the first comparison among inpatients with major depressive disorder, bipolar disorder, or obsessive–compulsive disorder. Journal of Psychiatric Research, 2021, 150:110604

10.Fernández-Alvarez, J, Grassi M, Colombo D, Botella C, Cipresso P, Perna G, Riva G, The Efficacy of Bio- and Neurofeedback for Depression: A Meta-analysis. Psychological Medicine, 2021, 15: 1-16.